Professor Mia Phillipson will present Nature Conferences Innovative Tissue Therapies from Bench to Bedside 16-18 November
Abstract: "The ILP-technology platform is scalable and enables efficient delivery of immunoregulatory proteins locally on-site – lead program in clinical phase 2 developments"